Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Product Differences Necessitate Some US FDA Inconsistency In Rare Diseases, Center Directors Say
Jul 08 2022
•
By
Derrick Gingery
Inconsistency is not the same as scientific disagreement, CDER Director Patrizia Cavazzoni said. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Product Reviews
More from Pink Sheet